ChengDu ShengNuo BiotecLtd Balance Sheet Health
Financial Health criteria checks 5/6
ChengDu ShengNuo BiotecLtd has a total shareholder equity of CN¥918.7M and total debt of CN¥398.9M, which brings its debt-to-equity ratio to 43.4%. Its total assets and total liabilities are CN¥1.5B and CN¥609.4M respectively. ChengDu ShengNuo BiotecLtd's EBIT is CN¥105.0M making its interest coverage ratio 13.7. It has cash and short-term investments of CN¥230.6M.
Key information
43.4%
Debt to equity ratio
CN¥398.93m
Debt
| Interest coverage ratio | 13.7x |
| Cash | CN¥230.62m |
| Equity | CN¥918.65m |
| Total liabilities | CN¥609.40m |
| Total assets | CN¥1.53b |
Recent financial health updates
No updates
Recent updates
ChengDu ShengNuo BiotecLtd (SHSE:688117) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Nov 04
ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117) Stocks Shoot Up 32% But Its P/E Still Looks Reasonable
Aug 26A Look At The Fair Value Of ChengDu ShengNuo Biotec Co.,Ltd. (SHSE:688117)
Jun 19ChengDu ShengNuo BiotecLtd (SHSE:688117) Strong Profits May Be Masking Some Underlying Issues
Apr 29There's Reason For Concern Over ChengDu ShengNuo Biotec Co.,Ltd.'s (SHSE:688117) Massive 27% Price Jump
Mar 04Financial Position Analysis
Short Term Liabilities: 688117's short term assets (CN¥651.4M) exceed its short term liabilities (CN¥467.4M).
Long Term Liabilities: 688117's short term assets (CN¥651.4M) exceed its long term liabilities (CN¥142.0M).
Debt to Equity History and Analysis
Debt Level: 688117's net debt to equity ratio (18.3%) is considered satisfactory.
Reducing Debt: 688117's debt to equity ratio has increased from 0.4% to 43.4% over the past 5 years.
Debt Coverage: 688117's debt is well covered by operating cash flow (20.2%).
Interest Coverage: 688117's interest payments on its debt are well covered by EBIT (13.7x coverage).